Abstract

Study background: Obstructive sleep apnea (OSA) is a common disease characterized by repetitive upper airway obstruction during sleep. OSA is associated with an increased risk of cardiovascular morbidity. Continuous positive airway pressure (CPAP) has been established as a standard therapy for OSA, but it is not always tolerated by OSA patients. Objective: In a pilot study, we evaluated the therapeutic effects of the nasal airway stent (NAS), a new nasopharyngeal device placed in the nasopharynx, on OSA and snoring. Methods: Six subjects with OSA were enrolled. The apnea-hypopnea index, oxygen desaturation index, lowest oxygen saturation, and snore index were analyzed before and during treatment with the NAS. Results: All subjects tolerated the NAS, with good compliance. Treatment with the NAS ameliorated apnea and hypopnea events and improved oxygen saturation in subjects with mild to moderate OSA. Snoring in all subjects was improved by the NAS. Conclusions: The NAS stent is a readymade device that could be an alternative therapy for patients with mild to moderate OSA who cannot tolerate CPAP or for subjects with snoring.

Highlights

  • Obstructive sleep apnea (OSA) is a common public health problem that affects as much as 4% of the adult population [1,2]

  • The nasal airway stent (NAS) stent is a readymade device that could be an alternative therapy for patients with mild to moderate OSA who cannot tolerate continuous positive airway pressure (CPAP) or for subjects with snoring

  • Nasopharyngeal appliances are currently available, unlike those appliances, the single NAS (s-NAS) is constructed of resilient silicone rubber that enables the upper airway to maintain the patency

Read more

Summary

Introduction

Obstructive sleep apnea (OSA) is a common public health problem that affects as much as 4% of the adult population [1,2]. Several therapies have been developed to treat OSA, including surgery and continuous positive airway pressure (CPAP) [7]. CPAP has been established as a standard therapy for patients with OSA [7,8,9]. It is effective, low patient tolerance remains an obstacle to be overcome [10,11]. The nasal trumpet has been used successfully to decrease airway obstruction in the short term, such as immediately after surgery for OSA [18]. The stiffness, length, and consequent discomfort of nasal trumpets mean that they need to be improved for long-term tolerability [18]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.